47 results on '"Milinković, Ivan"'
Search Results
2. Epidemiology of heart failure
3. Diagnostic and therapeutic practice for Heart Failure with preserved ejection fraction around the world: An international survey
4. Heart Failure Association, Heart Failure Society of America, and Japanese Heart Failure Society Position Statement on Endomyocardial Biopsy
5. The 'peptide for life' initiative in the emergency department study.
6. State‐of‐the‐art document on optimal contemporary management of cardiomyopathies
7. Adverse cardiovascular outcomes in atrial fibrillation: Validation of the new 2MACE risk score
8. State-of-the-art document on optimal contemporary management of cardiomyopathies
9. Mineralocorticoid receptor antagonists, a class beyond spironolactone — Focus on the special pharmacologic properties of eplerenone
10. Heart Failure Association/European Society of Cardiology Atlas second edition: new insights into understanding the burden of heart failure
11. Risk stratification models for predicting mortality in heart failure: a favourite or an outsider?
12. Medical Treatment of Heart Failure with Reduced Ejection Fraction in the Elderly
13. Navigating between Scylla and Charybdis: challenges and strategies for implementing guideline‐directed medical therapy in heart failure with reduced ejection fraction
14. Pericardial syndromes: an update after the ESC guidelines 2004
15. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy
16. The role of glycemia in acute heart failure patients
17. Sex and age-related differences in the quality of treatment, morbidity and mortality in heart failure patients
18. The Heart Failure Association Atlas: rationale, objectives, and methods
19. Uticaj pola i godina starosti bolesnika na kvalitet lečenja, morbiditet i mortalitet u srčanoj insuficijenciji
20. Organization of heart failure management in European Society of Cardiology member countries: survey of the Heart Failure Association of the European Society of Cardiology in collaboration with the Heart Failure National Societies/Working Groups
21. Oxidative stress and inflammation in heart failure: The best is yet to come
22. Type 2 diabetes increases the long‐term risk of heart failure and mortality in patients with atrial fibrillation
23. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology
24. Risk stratification models for predicting mortality in heart failure: a favourite or an outsider?
25. Sex‐ and Age‐Related Differences in the Management and Outcomes of Chronic Heart Failure: an Analysis of Patients from the ESC HFA EORP Heart Failure Long‐Term Registry
26. The Heart Failure Association Atlas: Heart Failure Epidemiology and Management Statistics 2019.
27. Age old problem: heart failure treatment in elderly
28. Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology
29. Lipoprotein apheresis and proprotein convertase subtilisin/kexin type 9 inhibitors: Do we have a vanquishing new strategy?
30. Type 2 diabetes mellitus and heart failure : a position statement from the Heart Failure Association of the European Society of Cardiology
31. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
32. Heart Failure Association of the European Society of Cardiology Quality of Care Centres Programme: design and accreditation document.
33. The Heart Failure Association Atlas: rationale, objectives, and methods.
34. Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry.
35. Type 2 diabetes increases the long-term risk of heart failure and mortality in patients with atrial fibrillation.
36. Long-term mortality is increased in patients with undetected prediabetes and type-2 diabetes hospitalized for worsening heart failure and reduced ejection fraction
37. Association of metabolic syndrome with non-thromboembolic adverse cardiac outcomes in patients with atrial fibrillation
38. A step forward in resolving an old issue: treatment of heart failure with preserved ejection fraction and renal dysfunction?
39. Type 2 diabetes mellitus and heart failure: a position statement from the Heart Failure Association of the European Society of Cardiology
40. Heart failure with improved ejection fraction: Is a newcomer in the family important?
41. Lipoprotein apheresis and proprotein convertase subtilisin/kexin type 9 inhibitors: Do we have a vanquishing new strategy?
42. Long-term mortality is increased in patients with undetected prediabetes and type-2 diabetes hospitalized for worsening heart failure and reduced ejection fraction.
43. Differential diagnosis and management of chronic pericarditis in the context of 2015 ESC guidelines on pericardial diseases
44. The Role of Ivabradine and Trimetazidine in the New ESC HF Guidelins
45. Pericardial syndromes: an update after the ESC guidelines 2004
46. Preoperative and perioperative management of patients with pericardial diseases.
47. Diabetic myocardial disorder. A clinical consensus statement of the Heart Failure Association of the ESC and the ESC Working Group on Myocardial & Pericardial Diseases.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.